Team Participation and Support Strategies for Patients With Metastatic Colorectal Cancer

In this third video in the series, learn how John L. Marshall, MD, and Bobbie Khan, MS, RN, OCN, provide patients with metastatic colorectal cancer support tools to help them better manage the multiple affects of their disease.
person default
Bobbie Khan, MS, RN, OCN
John L. Marshall, MD
Released: November 5, 2018

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Communicate treatment options with patients, considering the available data as well as their goals and preferences
  • Delineate to patients the rationale for adhering to prescribed medication and alerting the clinical team if symptoms arise
  • Partner with patients to ensure that they are equipped to make informed decisions and actively participate in their care
  • Provide psychosocial support to patients by activating their support group and expanding the community of support through available resources

Information on this Educational Activity

Faculty

John L. Marshall, MD

Chief, Division of Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

John L. Marshall, MD, has disclosed that he has received consulting fees from Amgen, Bayer, Caris, Celgene, Genentech, and Taiho; fees for non-CME services from Bayer, Celgene, Genentech, and Taiho; and funds for research support from Bayer, Caris, Celgene, Genentech, and Taiho.
Bobbie Khan, MS, RN, OCN

Clinical Nurse Coordinator
Lombardi Comprehensive Cancer Center
Medstar Georgetown University Hospital
Washington, DC

Bobbie Khan, MS, RN, OCN, has no real or apparent conflicts of interest to report.

Staff

Terrence Fagan

Associate Scientific Director

Terrence Fagan has no real or apparent conflicts of interest to report.
Krista Marcello

Scientific Director

Krista Marcello has no real or apparent conflicts of interest to report.
Kevin Obholz, PhD

Senior Director, Educational Strategy

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

Target Audience

This program is intended for oncologists, nurses, and other healthcare providers who care for patients with metastatic colorectal cancer.

Goal

The goal of this activity is to improve participants’ competence in equipping patients with metastatic colorectal cancer who have progressed after multiple lines of therapy to partner as part of a personalized care plan.

Program Medium

This program has been made available online.

Related Content

From Clinical Care Options, Tanios Bekaii-Saab, MD, reviews key data from studies of gastrointestinal cancer treatment presented at ASCO 2019.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 15, 2019 Expiration: August 14, 2020

Todd M. Bauer, MD; Marcia S. Brose, MD, PhD; and George D. Demetri, MD, discuss the latest data on TRK inhibitors in solid tumors with NTRK fusions.

Todd M. Bauer, MD Marcia S. Brose, MD, PhD George D. Demetri, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 15, 2019 Expiration: July 14, 2020

Drs. Todd M. Bauer, Giuseppe Giaccone, Axel Grothey, John L. Marshall, and Michael J. Pishvaian discuss the latest data on 10 key clinical biomarkers in solid tumors.

John L. Marshall, MD
Program Director
Todd M. Bauer, MD Giuseppe Giaccone, MD, PhD Axel Grothey Headshot Axel Grothey, MD Michael J. Pishvaian, MD, PhD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 11, 2019 Expiration: July 10, 2020

Novel KRASG12C inhibitor AMG 510 was tolerable and showed preliminary antitumor activity in KRASG12C-positive tumors, including NSCLC, as reported by CCO from ASCO 2019.

Released: June 5, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?